SOT Statistics

Total Valuation

Société de Therapeutique Marocaine has a market cap or net worth of MAD 6.82 billion. The enterprise value is 7.32 billion.

Market Cap	6.82B
Enterprise Value	7.32B

Important Dates

The next estimated earnings date is Thursday, October 31, 2024.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	Jun 21, 2024

Share Statistics

Société de Therapeutique Marocaine has 7.20 million shares outstanding.

Shares Outstanding	7.20M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.01%
Float	n/a

Valuation Ratios

The trailing PE ratio is 24.31 and the forward PE ratio is 24.40.

PE Ratio	24.31
Forward PE	24.40
PS Ratio	2.59
PB Ratio	4.48
P/FCF Ratio	273.71
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.35, with an EV/FCF ratio of 293.93.

EV / Earnings	26.67
EV / Sales	2.78
EV / EBITDA	15.35
EV / EBIT	17.62
EV / FCF	293.93

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.39.

Current Ratio	1.66
Quick Ratio	0.94
Debt / Equity	0.39
Debt / EBITDA	1.24
Debt / FCF	23.77
Interest Coverage	15.84

Financial Efficiency

Return on equity (ROE) is 18.95% and return on invested capital (ROIC) is 12.98%.

Return on Equity (ROE)	18.95%
Return on Assets (ROA)	8.85%
Return on Capital (ROIC)	12.98%
Revenue Per Employee	2.23M
Profits Per Employee	232,757
Employee Count	1,275
Asset Turnover	0.90
Inventory Turnover	1.76

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.84% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-9.84%
50-Day Moving Average	963.54
200-Day Moving Average	997.20
Relative Strength Index (RSI)	48.90
Average Volume (20 Days)	259

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Société de Therapeutique Marocaine had revenue of MAD 2.63 billion and earned 274.42 million in profits. Earnings per share was 38.10.

Revenue	2.63B
Gross Profit	1.19B
Operating Income	415.75M
Pretax Income	396.75M
Net Income	274.42M
EBITDA	472.74M
EBIT	415.75M
Earnings Per Share (EPS)	38.10

Full Income Statement

Balance Sheet

The company has 104.51 million in cash and 591.93 million in debt, giving a net cash position of -487.42 million or -67.70 per share.

Cash & Cash Equivalents	104.51M
Total Debt	591.93M
Net Cash	-487.42M
Net Cash Per Share	-67.70
Equity (Book Value)	1.54B
Book Value Per Share	211.12
Working Capital	858.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 143.44 million and capital expenditures -118.53 million, giving a free cash flow of 24.90 million.

Operating Cash Flow	143.44M
Capital Expenditures	-118.53M
Free Cash Flow	24.90M
FCF Per Share	3.46

Full Cash Flow Statement

Margins

Gross margin is 45.19%, with operating and profit margins of 15.81% and 10.44%.

Gross Margin	45.19%
Operating Margin	15.81%
Pretax Margin	15.09%
Profit Margin	10.44%
EBITDA Margin	17.98%
EBIT Margin	15.81%
FCF Margin	0.95%

Dividends & Yields

This stock pays an annual dividend of 17.00, which amounts to a dividend yield of 1.80%.

Dividend Per Share	17.00
Dividend Yield	1.80%
Dividend Growth (YoY)	-32.00%
Years of Dividend Growth	n/a
Payout Ratio	65.59%
Buyback Yield	n/a
Shareholder Yield	1.80%
Earnings Yield	4.02%
FCF Yield	0.37%

Dividend Details

Stock Splits

The last stock split was on July 13, 2021. It was a forward split with a ratio of 2.

Last Split Date	Jul 13, 2021
Split Type	Forward
Split Ratio	2

Scores

Société de Therapeutique Marocaine has an Altman Z-Score of 4.62.

Altman Z-Score	4.62
Piotroski F-Score	n/a